Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Considerations in the development of live biotherapeutic products for clinical use Ross JJ; Boucher PE; Bhattacharyya SP; Kopecko DJ; Sutkowski EM; Rohan PJ; Chandler DK; Vaillancourt JCurr Issues Mol Biol 2008[]; 10 (1-2): 13-6Food products in the United States (U.S.), including dietary supplements, may contain live microorganisms and can be promoted for general health, nutritional, or structure/function claims. In contrast, such preparations used with the intention of having a preventive or therapeutic effect in humans are regulated by the Food and Drug Administration (FDA) in the U.S. as biological products, specifically as live biotherapeutic products (LBPs). Discussion of considerations in the early development of LBPs may aid in preparation of an Investigational New Drug Application (IND) that is designed to collect clinical data to support marketing approval of a LBP in the U.S. for a specific clinical use. Product information is an important component of an IND to support a proposed clinical study.|*Drug Approval/legislation & jurisprudence[MESH]|Biological Products/*biosynthesis/chemistry/*therapeutic use[MESH]|Drug Design[MESH]|Humans[MESH]|Probiotics/*standards[MESH]|United States[MESH]|United States Food and Drug Administration/legislation & jurisprudence[MESH] |
